Author | Constantine S. Tam, MD | OncLive

Author | Constantine S. Tam, MD

Articles

Dr. Tam Discusses the Side Effect Profile of Duvelisib in CLL

February 08, 2018

Video

Constantine S. Tam, MD, associate professor, Peter MacCallum Cancer Centre, discusses the side effect profile of duvelisib in patients with chronic lymphocytic leukemia (CLL).

Dr. Tam Discusses the DUO Trial for CLL

February 01, 2018

Video

Constantine S. Tam, MD, associate professor, Peter MacCallum Cancer Centre, discusses, the randomized phase III DUO trial of duvelisib versus ofatumumab (Arzerra) in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Dr. Tam on the Toxicity of Ibrutinib Plus Venetoclax in MCL

October 25, 2017

Video

Constantine S. Tam, MD, associate professor, Peter MacCullum Cancer Centre, discusses the toxicities associated with the combination of ibrutinib (Imbruvica) and venetoclax (Venclexta) for patients with mantle cell lymphoma (MCL).

Dr. Tam on the Toxicities of Ibrutinib Plus Venetoclax in MCL

July 05, 2017

Video

Constantine S. Tam, MD, associate professor, Peter MacCullum Cancer Centre, discusses the toxicities of the phase II and phase III studies investigating the combination of ibrutinib (Imbruvica) plus venetoclax (Venclexta) for patients with mantle cell lymphoma (MCL).

x